Propanoic acid, 2-hydroxy-, butyl ester, (2S)-
Common Name: |
Propanoic acid, 2-hydroxy-, butyl ester, (2S)- |
IUPAC Name: |
butyl (2S)-2-hydroxypropanoate |
Molecular Formula: |
C10H18O2 |
SMILES: |
CCCCOC(=O)C(C)O |
Inchi: |
1S/C7H14O3/c1-3-4-5-10-7(9)6(2)8/h6,8H,3-5H2,1-2H3/t6-/m0/s1 |
Inchi Key: |
MRABAEUHTLLEML-LURJTMIESA-N |
Cas No: |
34451-19-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
170.25 |
Mass (g/mol) |
146.094 |
Molar Refractivity |
49.35 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-28 |
Boiling Point (°C@760.00mm Hg) |
185.00 to 187.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.156 |
Vapor Density (Air =1) |
4 |
Fraction Csp3 |
0.90 |
LogP |
0.71 |
iLOGP |
2.56 |
XLOGP3 |
2.72 |
WLOGP |
2.66 |
MLOGP |
2.19 |
ESOL Log S |
-2.28 |
ESOL Solubility (mg/ml) |
0.895 |
ESOL Solubility (mol/l) |
0.005 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.93 |
Ali Solubility (mg/ml) |
0.2 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.79 |
Silicos-IT Solubility (mg/ml) |
0.27 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.41 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.872 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.246 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |